Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1678660 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $4.71Day +1.51%Mkt cap $375M1Y +466.1%Off 52W high −17.2%Vol (1Y) 120.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,358 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.1% of sh out |
| Days to cover9.5d |
| 13F net flow (QoQ)+2.72% |
| Top-10 13F concentration89.5% |
| Next report (est.)2026-08-10 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$12.1M |
| Earnings (TTM)-$77.8M |
| ROE−99.5% |
| Net margin−819.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+62.4% |
| 1Y+466.1% |
| 3Y+20.5% |
| 5Y−85.6% |
| Since incept. (ann.)−39.6% |
Total return through 2026-07-29 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)120.8% |
| Ann. volatility (3Y)113.8% |
| Sharpe (1Y)2.05 |
| Sharpe (3Y)0.61 |
| Max drawdown (1Y)−38.4% |
| Max drawdown (3Y)−90.4% |
| Beta (3Y vs SPY)2.39 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10.9M | $37M | 13.70% | +0.0% |
| BAKER BROS. ADVISORS LP | 10.1M | $35M | 12.71% | +0.0% |
| Kynam Capital Management, LP | 1.6M | $5M | 2.00% | +101.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $4M | 1.54% | new |
| EcoR1 Capital, LLC | 947,049 | $3M | 1.19% | new |
| TWO SIGMA INVESTMENTS, LP | 923,626 | $3M | 1.16% | +17.1% |
| SPHERA FUNDS MANAGEMENT LTD. | 558,339 | $2M | 0.70% | +354.9% |
| ACADIAN ASSET MANAGEMENT LLC | 511,519 | $2M | 0.64% | −4.5% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | −$0.13 | — | $4.6M | — |
| 2025-09-30 | 2025-11-12 | −$0.26 | — | $6.5M | +116.7% |
| 2025-06-30 | 2025-08-14 | −$0.41 | — | — | — |
| 2025-03-31 | 2025-05-06 | −$0.42 | — | $0 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-10 is ESTIMATED from filing cadence (median gap 90d) — not company-confirmed.
